Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Background: Continuous glucose monitoring (CGM), which studies have shown is beneficial for adults with type 1 diabetes, has not been well-evaluated in those with type 2 diabetes receiving insulin. Objective: To determine the effectiveness of CGM in adults with type 2 diabetes receiving multiple daily injections of insulin. Design: Randomized clinical trial. (The protocol also included a type 1 diabetes cohort in a parallel trial and subsequent second trial.) (ClinicalTrials.gov: NCT02282397). Setting: 25 endocrinology practices in North America. Patients: 158 adults who had had type 2 diabetes for a median of 17 years (interquartile range, 11 to 23 years). Participants were aged 35 to 79 years (mean, 60 years [SD, 10]), were receiving multiple daily injections of insulin, and had hemoglobin A1c (HbA1c) levels of 7.5% to 9.9% (mean, 8.5%). Intervention: Random assignment to CGM (n = 79) or usual care (control group, n = 79). Measurements: The primary outcome was HbA1c reduction at 24 weeks. Results: Mean HbA1c levels decreased to 7.7% in the CGM group and 8.0% in the control group at 24 weeks (adjusted difference in mean change, -0.3% [95% CI, -0.5% to 0.0%]; P = 0.022). The groups did not differ meaningfully in CGM-measured hypoglycemia or quality-of-life outcomes. The CGM group averaged 6.7 days (SD, 0.9) of CGM use per week. Limitation: 6-month follow-up. Conclusion: A high percentage of adults who received multiple daily insulin injections for type 2 diabetes used CGM on a daily or near-daily basis for 24 weeks and had improved glycemic control. Because few insulin-treated patients with type 2 diabetes currently use CGM, these results support an additional management method that may benefit these patients. Primary Funding Source: Dexcom.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Benefits of CGM in this population include reductions in A1C, fewer severe hypoglycemia events in children and adults, increased TIR, as well as significant reductions in hospitalizations for severe hypoglycemia and DKA.156,162–168”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“The clinical efficacy of CGM has been demonstrated in numerous retrospective studies and RCTs of individuals with T1D regardless of insulin delivery method.156–161”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“In addition, CGM use has been reported to reduce fear of hypoglycemia and increase confidence in avoiding/treating hypoglycemia.156,174,175”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [156]
In the citing paper
“A1C is currently recognized as the key surrogate marker for the development of longterm diabetes complications in people with type 1 and type 2 diabetes and has been used the primary endpoint for many CGM studies (1; 3; 4; 6; 32; 33).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [4]
In the citing paper
“Numerous studies have demonstrated significant clinical benefits of CGM use in people with diabetes regardless of insulin delivery method (1-15).”
From Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (2019) · cites this paper as [4]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Assessing Psychosocial Distress in Diabetes
Polonsky, W. H., Fisher, L., Earles, J., Dudl, R. J., Lees, J., Mullan, J., & Jackson, R. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.626 · Cited by 1,575
Self-citationContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185 · cited 3×
“org), was identical to that of a parallel trial in patients with type 1 diabetes (12), which also had a second phase assessing insulin pump initiation.”
BackgroundResultSelf-citationEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Self-citationClarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651
Self-citationHaak, T., Hanaire, H., Ajjan, R., Hermanns, N., Riveline, J.-P., & Rayman, G. (2017) · Diabetes Therapy · doi:10.1007/s13300-016-0223-6 · Cited by 623
Pickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493
Cited by
Items 501–600 of 636
Tillman, J. B., Beck, R. W., Polonsky, W. H., Calhoun, P., Mouse, T., Bailey, R., Jacoby, J., Nandan, R., Sheikh, F. N., & Malone, J. K. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae778 · Cited by 1
Self-citation2023 Clinical Practice Guidelines for Diabetes: Continuous Glucose Monitoring and Insulin Pumps
Jin, S. (2023) · Journal of Korean Diabetes · doi:10.4093/jkd.2023.24.3.141 · Cited by 1
Simonson, D. C., Testa, M. A., Ekholm, E., Su, M., Vilsbøll, T., Jabbour, S. A., & Lind, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae105 · Cited by 2
Lazar, D., Tao, M., Matievich, W., Kastanos, K., & Dunn, T. C. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241260038 · Cited by 2
Adoption of Diabetes Technology in Denmark: Continuous Glucose Monitor as Time-Machine
Anesen, A. A. (2024) · Medical Anthropology · doi:10.1080/01459740.2024.2362883 · Cited by 1
Marshall, B. A., Shih, I. C. F., Abuphilipous, M., Park, C., Vohra-Khullar, P. D., & Hassan, S. (2024) · Journal of General Internal Medicine · doi:10.1007/s11606-024-08941-1 · Cited by 2
Innovation is the driver behind quality improvements in diabetes care delivery
Hirsch, I. B., & Parkin, C. G. (2024) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2024.30.10-b.s2 · Cited by 1
Kinny, F., Sherazi, B. A., Dabidian, A., Laeer, S., & Obarcanin, E. (2024) · Pharmacy · doi:10.3390/pharmacy12050154 · Cited by 1
Cebada, A. B., Silva, J. B. Q., Escobar-Morreale, H. F., & Chávez, L. N. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.10.010 · Cited by 5
Udby, D. L., Smith, D. K., Cushman, N. A., Vue, M., Reyes‐Gastelum, D., Klapperich, A., Ohman, T., Hromika, A. J., & Mackler, E. R. (2025) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.2075 · Cited by 1
Thurston, J., Li, H., Rajan, M., Baratt, Y., Bradley, A. M., & Pelzman, F. N. (2025) · Journal of Pharmacy Practice · doi:10.1177/08971900251327078 · Cited by 3
Logothetis, G., Avramidis, K., Konstantaki, E., Matziou, V. N., & Doupis, J. (2025) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2025.21.1.7 · Cited by 1
Temporal patterns of inpatient hypoglycaemia are treatment-dependent
Chan, W. O. Y., Lim, P. S., Ang, L. C., Goh, S., Bee, Y. M., & Teh, M. M. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251338749 · Cited by 1
Assessing the Financial Sustainability of a Virtual Clinic Providing Comprehensive Diabetes Care
Dupenloup, P., Guan, G., Aleppo, G., Bergenstal, R. M., Hood, K. K., Kruger, D. F., MCARTHUR, T. S., Olson, B. A., Oser, S. M., Oser, T. K., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251340664 · Cited by 2
Self-citationCorrelation of HbA1c and Continuous Glucose Monitor Time in Range
DePasquale, H., DeLucenay, A., & Ahmed‐Sarwar, N. (2025) · Journal of Pharmacy Technology · doi:10.1177/87551225251348832 · Cited by 3
Jahed, S. A., Nikoosokhan, A., Moravej, H., Sarkheil, P., Malek, M., Esteghamati, A., Hosseinpanah, F., & Sedaghat, S. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112961 · Cited by 1
A Review of Automated Insulin Delivery Use in Type 1 Diabetes During Pregnancy
Young, E., Goyette, A. R., Alkire, J. F., Khachemoune, N. L., Bellini, N. J., & Isaacs, D. M. (2025) · Endocrine Practice · doi:10.1016/j.eprac.2025.10.015 · Cited by 1
Banu, Q. S., Donatien, C., Ramdeen, S., Calixte, R., Khaimova, R., Budovich, A., & Thomas, N. (2025) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514251389034 · Cited by 1
Scoping review of subcutaneous glucose monitoring techniques
Hrubá, E., Kubíček, J., & Augustýnek, M. (2025) · Measurement · doi:10.1016/j.measurement.2025.119940 · Cited by 1
Alshannaq, H. A., Simmons, D. S., Matuoka, J. Y., Pollock, R. F., Tucker, M., Ahmed, M. U., & Norman, G. J. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03430-1 · Cited by 3
Cellino, C. A. K., Chen, E.-L., Pawelek, J., Daly, C. J., Jacobs, D. M., & Prescott, G. M. (2026) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2025.103016 · Cited by 4
Lian, X., Cheng, L. J., Teo, C. J. Y., Tan, J., Lim, H., Shen, L., Chew, H. S. J., Wang, W., & Dalan, R. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1761579 · Cited by 1
Fathi, A. E., Nass, R. M., Levy, C. J., Levister, C. M., O’Malley, G., Shah, N. A., Hassan, S., Quainoo, C., Koravi, C. L. K., NGUYEN, T., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261420193 · Cited by 1
Grady, M., MacKintosh, S., Fryett, M., Phillips, S., & Holt, E. (2026) · Journal of Diabetes Science and Technology · doi:10.1177/19322968261429941 · Cited by 1
Addressing barriers to CGM prescriptions in primary care: a quality improvement initiative
Yoo, A., Cherayil, N. A., ROSADO, R. M. S., & Rubin, A. (2026) · BMJ Open Quality · doi:10.1136/bmjoq-2025-003654 · Cited by 1
Pal, A. W., Chong, W. L., Huri, H. Z., & Ratnasingam, J. (2026) · Diabetic Medicine · doi:10.1111/dme.70360 · Cited by 1
Gómez, P. R. D. V., Mayoral, E., Jiménez, B. R., Peralta, F. G., Umpierrez, G. E., & Martínez‐Brocca, M. A. (2026) · Diabetes Care · doi:10.2337/dc26-0547 · Cited by 1
Should all patients on insulin be using continuous glucose monitoring?
Distiller, L. A. (2018) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2018.1515164 · Cited by 1
Lensing, C. J., Garth, S. R., Ehlert, B., Duerr, J. M., Wagner, C. D., Kapov, K. A., Jones, J. P., & Hoversten, S. (2019) · Diabetes Spectrum · doi:10.2337/ds19-0005 · Cited by 1
Wo steht das künstliche Pankreas in der Diabetestherapie?
Dimou, M., Laimer, M. W., Stettler, C., & Bally, L. (2019) · Der Internist · doi:10.1007/s00108-019-00713-y · Cited by 1
Hayek, A. A., Alzahrani, W. M., Sobki, S. H., Alsaeed, A. H., & Dawish, M. A. A. (2023) · Cureus · doi:10.7759/cureus.33416 · Cited by 4
Kim, M. S., Ryu, J. M., Kang, M., Park, J., Ahn, Y. C., & Kim, Y. S. (2023) · Journal of Health Informatics and Statistics · doi:10.21032/jhis.2023.48.1.36 · Cited by 1
Manov, A. E., Dhillon, G. S., Chauhan, S., Asllanaj, B., & Uy, E. S. (2023) · Cureus · doi:10.7759/cureus.36970 · Cited by 2
The Application of Digital Health in Diabetes Management
Ye, J. (2023) · Highlights in Science Engineering and Technology · doi:10.54097/hset.v66i.11711 · Cited by 1
An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy
Mennini, F. S., Sciattella, P., Marcellusi, A., Bartolini, F., Bernardi, F. F., Levrat‐Guillen, F., Cozzolino, M., Gennaro, M. D., Giordana, R., Giustozzi, M., et al. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01580-z · Cited by 1
Seufert, J., Dänschel, I., Gölz, S., Haller, N., Kulzer, B., Tan, S., Schnell, O., Wiesner, T., & Kroeger, J. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2305-9093 · Cited by 1
Besen, D. B., Dervişoğlu, M., & Şahin, L. (2024) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-024-01395-5 · Cited by 1
Continuous Glucose Monitoring in Individuals With Type 2 Diabetes: A Quality Improvement Program
Kinson, L., & Inman, K. (2024) · Clinical Diabetes · doi:10.2337/cd24-0006 · Cited by 5
Shomali, M. E., Kelly, C., Kumbara, A., Iyer, A., Park, J., & Aleppo, G. (2024) · Diabetes Spectrum · doi:10.2337/ds24-0032 · Cited by 2
Mind the Gap: Wearable Lactate and Glucose Monitors for Hospitalized Patients
Guzzi, J., Falter, F., Kumar, A. B., & Perrino, A. C. (2025) · Cureus · doi:10.7759/cureus.78536 · Cited by 3
Duan, Y., Ding, L., Gao, Z., Wang, Y., Cao, H., Zhang, H., & Yao, L. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-090664 · Cited by 2
Cheng, K. K., Cruz, M. F. V., Tylee, T. S., & Kelly, M. S. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251320122 · Cited by 1
Dynamic Interference Testing Results with the Dexcom G6 Continuous Glucose Monitoring Device
Thomé, N., Jensch, H., Srikanthamoorthy, G., Weingärtner, L., Grady, M., Setford, S. J., Holt, E., & Pfützner, A. (2025) · Diabetes Technology and Obesity Medicine · doi:10.1089/dtom.2024.0009 · Cited by 1
Considerations With Using a CGM in Older Individuals
Tadros, M., Sewell, H. E., & O’Neal, K. S. (2025) · The Senior Care Pharmacist · doi:10.4140/tcp.n.2025.283 · Cited by 1
Achievement of time in range goals among patients with diabetes using continuous glucose monitoring
Azizi, F., Diehl, K., Enser, L., & Heacock, S. (2025) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2025.102924 · Cited by 1
Paglialunga, S., Morimoto, B. H., de la Peña, A., & Fortier, C. (2018) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.437 · Cited by 2
Feldman, H. A. (2020) · Physician Assistant Clinics · doi:10.1016/j.cpha.2019.12.001 · Cited by 1
Primary Care and Diabetes Technologies and Treatments
Simonson, G. D., Martens, T. W., Carlson, A. L., & Bergenstal, R. M. (2022) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2022.2509 · Cited by 1
Self-citationSeven facts you need to know about continuous glucose monitors
Solano, L. (2022) · JAAPA · doi:10.1097/01.jaa.0000854536.09072.5e · Cited by 1
Commentary On Measurements of Glycemic Control
Gilden, J. L. (2018) · Endocrine Practice · doi:10.4158/ep-2017-0150 · Cited by 1
Haak, T. (2018) · Annals of Internal Medicine · doi:10.7326/l17-0705 · Cited by 3
Continuous Glucose Monitoring Can Lower HbA
Soloway, B. (2017) · Journal watch · doi:10.1056/nejm-jw.na44864
Parkin, C. G. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0241
Technologische Innovationen in der Diabetes-Therapie
Strey, C. H. (2018) · Praxis · doi:10.1024/1661-8157/a003058
Studies find novel approaches result in improved glycemic control in diabetes
Tanzi, M. G. (2017) · Pharmacy Today · doi:10.1016/j.ptdy.2017.10.023
Newer Modalities in the Treatment of Type 2 Diabetes Mellitus: Focus on Technology
Schorr, A. B. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.84285
Continuous and flash glucose monitoring in diabetes
Morris, D. (2019) · Journal of Prescribing Practice · doi:10.12968/jprp.2019.1.sup3.s3
Evaluation of a Diabetic Point of Care Education in Primary Care
Cho, M. (2019) · UKnowledge (University of Kentucky)
Role of Continuous Glucose Monitoring Technology for Type 2 Diabetes Management
Taylor, P. (2019) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
CGM-101: How to Identify Appropriate Use
Howell, C., & Meredith, A. H. (2020) · ADCES in Practice · doi:10.1177/2633559x20925456
Westman, K., Imberg, H., Albrektsson, H., Hirsch, I. B., Tuomilehto, J. O., Dahlqvist, S., & Lind, M. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.11.005
Zhang, W., Liu, Y., Sun, B., Shen, Y., Li, M., Peng, L., Duan, H., Su, X., Lu, S., Tian, X., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-657144/v1
Gargallo-Fernández, M., Menéndez, S. A., César, M. J. P., & Reyes‐García, R. (2021) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2021.04.006 · Cited by 2
Gargallo-Fernández, M., Menéndez, S. A., César, M. J. P., & Reyes‐García, R. (2021) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2021.11.028
Glucose Monitoring and Sensing
Pickup, J. C., & Oliver, N. S. (2022) · doi:10.1093/med/9780198870197.003.0251
Kommentar zu Kontinuierliche Glukosemessung: am besten dauerhaft beibehalten!
Ritzel, R. A. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1732-8882
A folyamatos glükózmonitorozás jelentősége a korszerű diabetesgondozásban
Kocsis, G. (2022) · Lege Artis Medicinae · doi:10.33616/lam.32.016
Assessment of accuracy and glycemic control of FGM and CGM and impact on mental well-being
Gesslbauer, M., Koehler, G., Baumgärtner, C., & Šajić, J. L. (2022) · Current Directions in Biomedical Engineering · doi:10.1515/cdbme-2022-1002
Application of Continuous Glucose Monitoring Systems in Patients With Type 2 Diabetes Mellitus
(2022) · European Journal of Medicine · doi:10.13187/ejm.2022.1.12 · Cited by 1
de Boer, I. H., & Hirsch, I. B. (2023) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000000000000125
What Do You Need to Know About Continuous Glucose Monitoring?
Cedeno, A., & Carmichael, K. A. (2021) · Consultant · doi:10.25270/con.2021.01.00006
Moon, S. J., Hong, J. H., Kim, S. S., Kim, K., Lim, S. K., Jin, H. Y., Hwang, Y., Lee, S., Lee, K., Kang, J. G., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4608008
Merino, M., Hidalgo‐Vega, Á., Anzola, S. C., Sarría‐Santamera, A., Baro, M. A., Romero, J. M. G., Merino-Torres, J. F., Serra, O. D. S.-M., & Beato-Víbora, P. I. (2021) · Economía de la Salud · doi:10.61679/1602023041
New Technologies for Glucose Monitoring
Danne, T., & Kordonouri, O. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch32
Positioning “Time-in-Range” in the Treatment of Diabetes in India
Mohan, V., Unnikrishnan, A. G., Kesavadev, J., & Saboo, B. (2022) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_2_22
Perfilando la tecnología en diabetes
Gómez, N. B., Jiménez-Salazar, S., Delgado, M. R., Botero, J. F., & Rincón, A. R. (2024) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.11.1.852
Zhang, D., Yang, Y., Zhang, J., Chen, J., Huang, L., Zhang, L., & Liu, X. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4791181
Hirsch, B. R. (2024) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000000993
Jecht, M. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01215-8
Kong, S.-Y., & Cho, M. (2024) · Healthcare · doi:10.3390/healthcare12141381 · Cited by 3
Steenkamp, D. (2021) · American Diabetes Association eBooks · doi:10.2337/9781580407694.ch07
Indications, specifics and reimbursement of glucose sensors in type 2 diabetes patients
Štechová, K. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.077
Wie genau ist eine kontinuierliche Blutzuckermessung im Krankenhaus?
Jecht, M. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01249-y
Continuous Glucose Monitoring for Inpatients on Intravenous Insulin
GOOD, K. L., Joshi, R., & SNELL, V. M. (2025) · Clinical Nurse Specialist · doi:10.1097/nur.0000000000000888
Aljohani, R. A., Altaib, H. N., & Kofi, M. A. (2025) · Cureus · doi:10.7759/cureus.79705 · Cited by 1
Sobczak, C., Oser, S. M., Warman, M., Daffron, A., Buss, D., Wettergreen, S. A., Oser, T. K., Parascando, J. A., & Jortberg, B. T. (2025) · ADCES in Practice · doi:10.1177/2633559x251328956
Clinical pharmacist roles in a virtual continuous glucose monitor initiation service
Wettergreen, S. A., Sobczak, C., Jortberg, B. T., Oser, S. M., Buss, D., Parascando, J. A., Daffron, A., & Oser, T. K. (2025) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.70046
Eer, A., Hachem, M., Hearn, T., Koye, D. N., Atkinson‐Briggs, S., Jones, J. L., Eades, S., Braat, S., Twigg, S. M., Sinha, A. K., et al. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01607-7
Mansuri, S., Song, M. W., & Amico, J. (2025) · Evidence-Based Practice · doi:10.1097/ebp.0000000000002436
Alshannaq, H. A., Matuoka, J. Y., Pollock, R. F., Ahmed, W., Lynch, P. M., & Norman, G. J. (2025) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2025.31.8.752 · Cited by 2
Badawi, S. A. A., Alhajri, A. H. M., Altayb, N. M. O., Mohmmed, E., Hassabelrasoul, R. K. E., Mohammed, S. A. S., Mohammed, W. H. A., & Ghali, J. A. E. (2025) · Cureus · doi:10.7759/cureus.89534 · Cited by 3
Stout, H. K., Planas, L. G., Sewell, H. E., Nadig, A. P., & O’Neal, K. S. (2025) · ADCES in Practice · doi:10.1177/2633559x251366099
Case Studies From India: Management of Diabetes Using Continuous Glucose Monitoring
Gupta, A. K., Krishnan, A. S., Kataria, M., & Jain, N. (2025) · Cureus · doi:10.7759/cureus.93177 · Cited by 2
Mohammadi, A., Daroudi, R., Mousavi, A., Olyaeemanesh, A., Nasli‐Esfahani, E., Shafiee, G., Heshmat, R., Takian, A., & Darvishi, A. (2025) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2025.2586670
Medications for the Management of Hypoglycemia
Giruzzi, M. E. (2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch28
UNDERWOOD, P. C., Babicheva, V., Keels, J. N., Flewelling, C., Petreca, V. G., Magny‐Normilus, C., & Upadhay, J. (2026) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106251405751
Dwiastuti, A., Latarissa, I. R., Hidayat, A., Halimah, E., & Lestari, K. (2026) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s561759 · Cited by 2
Severe Hypoglycemia in Insulin-Treated Type 2 Diabetes: A Call to Revisit Diabetes Education
Bilal, A., Osorio, S., & Casu, A. (2026) · Diabetes Care · doi:10.2337/dci25-0117 · Cited by 2
Metadata
- Authors
- Beck, R. W., Riddlesworth, T. D., Ruedy, K., Ahmann, A., Haller, S., Kruger, D., McGill, J. B., Polonsky, W., Price, D., Aronoff, S., Aronson, R., Toschi, E., Kollman, C., Bergenstal, R., & for the DIAMOND Study Group*
- Affiliations
- Joslin Diabetes Center (US)
- ORCID
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2017-09-19
- Volume
- 167
- Issue
- 6
- Pages
- 365-374
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2753830550
- Semantic Scholar
- 4f35ac21c54271e1101cc587d928e543765ee06a
- Cited by
- 635
- References
- 31
- Citations by year
- 2026: 58 · 2025: 91 · 2024: 95 · 2023: 77 · 2022: 77 · 2021: 85 · 2020: 43 · 2019: 56 · 2018: 46 · 2017: 6
- FWCI
- 32.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- continuous glucose monitoring, type 2 diabetes, multiple daily insulin injections, glycemic control, HbA1c reduction, hypoglycemia, quality of life, usual care, type 1 diabetes
- MeSH terms
- Adult, Aged, Bacterial Proteins, Diabetes Mellitus, Type 2, Drug Administration Schedule, Glycated Hemoglobin, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Membrane Proteins, Middle Aged, Quality of Life, Blood Glucose Self-Monitoring, Patient Satisfaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.